The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Open accessAbstract
In undergraduate level organometallic chemistry courses students are usually taught that organometallic compounds are toxic and unstable in air and water. While this is true of many complexes, some are also non-toxic and stable in air and water. Indeed, bioorganometallic chemistry, the study of biomolecules or biologically active molecules that contain at least one carbon directly bound to a metal, is a thriving subject, and air and water stability is a general pre-requisite. This interdisciplinary field is located at the borderline between chemistry, biochemistry, biology and medicine. In this tutorial review, various aspects of bioorganometallic chemistry are introduced, with the main emphasis on medicinal organometallic compounds. Organometallic therapeutics for cancer, HIV and malaria and other medicinal applications are described. It is also shown how rational ligand design has led to new improved therapies much in the same way that an organometallic chemist working in catalysis will design new ligands for improved activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applied Homogeneous Catalysis with Organometallic Compounds
(2002) · Wiley eBooks · doi:10.1002/9783527618231 · Cited by 2,231
Bioorganometallic Chemistry of Ferrocene
van Staveren, D. R., & Metzler-Nolte, N. (2004) · Chemical Reviews · doi:10.1021/cr0101510 · Cited by 1,319
Hartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956
Self-citationAntitumour metal compounds: more than theme and variations
Jakupec, M. A., Galanski, M. S., Arion, V. B., Hartinger, C. G., & Keppler, B. K. (2008) · Dalton Transactions · doi:10.1039/b712656p · Cited by 850
Self-citationHartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
Self-citationMetal-based antitumour drugs in the post genomic era
Dyson, P. J., & Sava, G. (2006) · Dalton Transactions · doi:10.1039/b601840h · Cited by 771
Self-citationClassical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy
Ang, W. H., & Dyson, P. J. (2006) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200600723 · Cited by 713
Self-citationCardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule
Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., Foresti, R., & Motterlini, R. (2003) · Circulation Research · doi:10.1161/01.res.0000084381.86567.08 · Cited by 673
Receptor-mediated endocytosis of transferrin in K562 cells.
Klausner, R. D., Van Renswoude, J., Ashwell, G., Kempf, C., Schechter, A. N., Dean, A., & Bridges, K. R. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32481-5 · Cited by 564
N-Heterocyclic carbene–silver complexes: A new class of antibiotics
Kascatan-Nebioglu, A., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.08.019 · Cited by 479
Tumour-inhibiting platinum complexes—state of the art and future perspectives
Jakupec, M. A., Galanski, M. S., & Keppler, B. K. (2003) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/s10254-002-0001-x · Cited by 434
Fish, R. H., & Jaouen, G. (2003) · Organometallics · doi:10.1021/om0300777 · Cited by 328
Casini, A., Hartinger, C., Gabbiani, C., Mini, E., Dyson, P. J., Keppler, B. K., & Messori, L. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.11.003 · Cited by 267
Self-citationMarcon, G., Carotti, S., Coronnello, M., Messori, L., Mini, E., Orioli, P., Mazzei, T., Cinellu, M. A., & Minghetti, G. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010997w · Cited by 266
Iron-only hydrogenase: Synthetic, structural and reactivity studies of model compounds
LIU, X., IBRAHIM, S., TARD, C., & PICKETT, C. (2005) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2005.04.009 · Cited by 264
Metal Carbonyls: A New Class of Pharmaceuticals?
Johnson, T. R., Mann, B. E., Clark, J. E., Foresti, R., Green, C. J., & Motterlini, R. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200301634 · Cited by 261
Ruthenium Half‐Sandwich Complexes Bound to Protein Kinase Pim‐1
Debreczeni, J. É., Bullock, A. N., Atilla, G. E., Williams, D. S., Bregman, H., Knapp, S., & Meggers, E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503468 · Cited by 234
Smalley, K. S. M., Contractor, R., Haass, N. K., Kulp, A. N., Atilla-Gokcumen, G. E., Williams, D. S., Bregman, H., Flaherty, K. T., Soengas, M. S., Meggers, E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1538 · Cited by 230
Guo, M., Sun, H., McArdle, H. J., Gambling, L., & Sadler, P. J. (2000) · Biochemistry · doi:10.1021/bi000798z · Cited by 228
New Principles in Medicinal Organometallic Chemistry
Schatzschneider, U., & Metzler‐Nolte, N. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200504604 · Cited by 194
Development of Ruthenium Antitumor Drugs that Overcome Multidrug Resistance Mechanisms
Vock, C. A., Ang, W. H., Scolaro, C., Phillips, A. D., Lagopoulos, L., Juillerat-Jeanneret, L., Sava, G., Scopelliti, R., & Dyson, P. J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070039f · Cited by 185
Self-citationTransferrin As A Targeting Ligand for Liposomes and Anticancer Drugs
Singh, M. (1999) · Current Pharmaceutical Design · doi:10.2174/138161280506230110111312 · Cited by 181
Mann, B. E., & Motterlini, R. (2007) · Chemical Communications · doi:10.1039/b704873d · Cited by 172
Influence of Hydrogen-Bonding Substituents on the Cytotoxicity of RAPTA Compounds
Scolaro, C., Geldbach, T. J., Rochat, S., Dorcier, A., Gossens, C., Bergamo, A., Cocchietto, M., Tavernelli, I., Sava, G., Röthlisberger, U., et al. (2005) · Organometallics · doi:10.1021/om0508841 · Cited by 157
Self-citationAuzias, M. G., Therrien, B., Süß‐Fink, G., Štěpnička, P., Ang, W. H., & Dyson, P. J. (2007) · Inorganic Chemistry · doi:10.1021/ic7018742 · Cited by 144
Self-citationGaiddon, C., Jeannequin, P., Bischoff, P., Pfeffer, M., Sirlin, C., & Loeffler, J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089342 · Cited by 142
Randaccio, L., Furlan, M., Geremia, S., Šlouf, M., Šloufová, I., & Toffoli, D. (2000) · Inorganic Chemistry · doi:10.1021/ic0001199 · Cited by 138
Organometallic Ruthenium Inhibitors of Glutathione‐S‐Transferase P1‐1 as Anticancer Drugs
Ang, W. H., Luca, A. D., Chapuis‐Bernasconi, C., Juillerat‐Jeanneret, L., Bello, M. L., & Dyson, P. J. (2007) · ChemMedChem · doi:10.1002/cmdc.200700209 · Cited by 126
Self-citationMetal-Based Paullones as Putative CDK Inhibitors for Antitumor Chemotherapy
Schmid, W. F., John, R. O., Mühlgassner, G., Heffeter, P., Jakupec, M. A., Galanski, M. S., Berger, W., Arion, V. B., & Keppler, B. K. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701042w · Cited by 89
Ward, T. R. (2005) · Chemistry - A European Journal · doi:10.1002/chem.200401232 · Cited by 87
Unraveling the Structure and Mechanism of Acetyl-Coenzyme A Synthase
Hegg, E. L. (2004) · Accounts of Chemical Research · doi:10.1021/ar040002e · Cited by 84
Guo, M., Guo, Z., & Sadler, P. J. (2001) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750100248 · Cited by 82
A self-assembled, redox-responsive receptor for the selective extraction of LiCl from water
Piotrowski, H., & Severin, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062663899 · Cited by 78
The active site of Ni-Fe hydrogenases: model chemistry and crystallographic results
Fontecilla-Camps, J. C. (1996) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750050027 · Cited by 71
Antitumour activity of oxaliplatin in neuroblastoma cell lines
Riccardi, A., Ferlini, C., Meco, D., Mastrangelo, R., Scambia, G., & Riccardi, R. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00342-6 · Cited by 34
Cited by
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Application of Metal Coordination Chemistry To Explore and Manipulate Cell Biology
Haas, K. L., & Franz, K. J. (2009) · Chemical Reviews · doi:10.1021/cr900134a · Cited by 984
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Liu, W., & Gust, R. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35314h · Cited by 762
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Metadata
- Authors
- Hartinger, C. G., & Dyson, P. J.
- Venue
- Chem. Soc. Rev.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2009
- Volume
- 38
- Issue
- 2
- Pages
- 391-401
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2159733863
- Cited by
- 985
- References
- 35
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.